Stem Cell Transplantation With NiCordĀ® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
Gamida Cell ltd
Gamida Cell ltd
Brown University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Celgene
Centre Leon Berard
University College, London
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Sumitomo Pharma America, Inc.
Fate Therapeutics
Karyopharm Therapeutics Inc
Opna Bio LLC
Duke University
Northside Hospital, Inc.
Gamida Cell ltd
Jazz Pharmaceuticals
National Cancer Institute (NCI)
Icahn School of Medicine at Mount Sinai
Kiadis Pharma
Case Comprehensive Cancer Center
Kiadis Pharma
Fred Hutchinson Cancer Center
Novartis
Dartmouth-Hitchcock Medical Center
Gamida Cell ltd
Fred Hutchinson Cancer Center
Celgene
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Celgene
Fred Hutchinson Cancer Center
Regimmune Corporation
University of Utah
University of Arizona
Ann & Robert H Lurie Children's Hospital of Chicago
Agios Pharmaceuticals, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
Takeda
Gruppo Italiano Malattie EMatologiche dell'Adulto
Celgene
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Prescient Therapeutics, Ltd.